61/100B51.365
USD
-0.33
(-0.64%)
Market Closed
Last updated: · Delayed 15 min
Fair valueNot reliable
Q4 FY2026 · Earnings report
EPS estimate 0.23Revenue estimate 1.25B
Q4 FY2026 · Earnings report
EPS estimate 0.23Revenue estimate 1.25B
Genmab A debt to equity ratioWhat is the debt to equity ratio? Debt to equity is a company's total debt divided by its shareholders' equity: how much it has borrowed for each dollar its owners have in the business.
Genmab A/S ADS's debt to equity ratio is 0.82: total debt of 5.20B USD against shareholders' equity of 6.33B USD.
- Today
- 0.82
- Average, 5 years
- 0.20
- Low, 5 years
- 0.02
- High, 5 years
- 0.94
Debt to equity = total debt ÷ shareholders' equity = 5.20B ÷ 6.33B = 0.82
Debt to equity
Total debt
Shareholders' equity
Total debt over shareholders' equity at each quarter end.
Debt to equity by year and by quarter
| Fiscal year | Period ending | Debt to equity | Total debt | Shareholders' equity |
|---|---|---|---|---|
| Today | 0.82 | 5.20B | 6.33B | |
| FY2025 | 31 Dec 2025 | 0.93 | 5.43B | 5.83B |
| FY2024 | 31 Dec 2024 | 0.03 | 1.03B | 36.70B |
| FY2023 | 31 Dec 2023 | 0.02 | 770.00M | 31.61B |
| FY2022 | 31 Dec 2022 | 0.02 | 597.00M | 27.28B |
| FY2021 | 31 Dec 2021 | 0.02 | 425.00M | 22.20B |
| FY2020 | 31 Dec 2020 | 0.02 | 319.00M | 19.12B |
| FY2019 | 31 Dec 2019 | 0.01 | 181.00M | 14.05B |
| FY2018 | 31 Dec 2018 | 0.00 | 0.00 | 8.01B |
| FY2017 | 31 Dec 2017 | 0.00 | 0.00 | 6.27B |
| FY2016 | 31 Dec 2016 | 0.00 | 0.00 | 4.83B |
| FY2015 | 31 Dec 2015 | 0.00 | 118.00K | 3.49B |
| FY2014 | 31 Dec 2014 | 0.00 | 355.00K | 2.03B |
| FY2013 | 31 Dec 2013 | 0.00 | 2.49M | 659.52M |
| FY2012 | 31 Dec 2012 | 0.01 | 5.66M | 383.19M |
| FY2011 | 31 Dec 2011 | 0.02 | 11.85M | 486.42M |
| FY2010 | 31 Dec 2010 | 0.12 | 133.72M | 1.08B |
| FY2009 | 31 Dec 2009 | 0.02 | 24.94M | 1.30B |
| FY2008 | 31 Dec 2008 | 0.01 | 14.70M | 2.19B |
| FY2007 | 31 Dec 2007 | 0.01 | 15.67M | 2.88B |
| FY2006 | 31 Dec 2006 | 0.01 | 18.21M | 1.61B |
| FY2005 | 31 Dec 2005 | 0.02 | 23.04M | 1.12B |
| FY2004 | 31 Dec 2004 | 0.02 | 29.00M | 1.18B |
| FY2003 | 31 Dec 2003 | 0.02 | 24.14M | 1.09B |
| FY2002 | 31 Dec 2002 | 0.01 | 13.78M | 1.40B |
| Quarter | Period ending | Debt to equity | Total debt | Shareholders' equity |
|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 0.82 | 5.20B | 6.33B |
| Q2 FY2026 | 30 Jun 2026 | 0.89 | 5.27B | 5.96B |
| Q1 FY2026 | 31 Mar 2026 | 0.94 | 5.35B | 5.68B |
| Q4 FY2025 | 31 Dec 2025 | 0.93 | 5.43B | 5.83B |
| Q3 FY2025 | 30 Sept 2025 | 0.02 | 142.00M | 5.75B |
| Q2 FY2025 | 30 Jun 2025 | 0.03 | 147.97M | 5.30B |
| Q1 FY2025 | 31 Mar 2025 | 0.03 | 138.04M | 4.95B |
| Q4 FY2024 | 31 Dec 2024 | 0.03 | 1.03B | 36.70B |
| Q3 FY2024 | 30 Sept 2024 | 0.03 | 987.00M | 31.92B |
| Q2 FY2024 | 30 Jun 2024 | 0.03 | 1.02B | 30.97B |
| Q1 FY2024 | 31 Mar 2024 | 0.03 | 1.01B | 32.50B |
| Q4 FY2023 | 31 Dec 2023 | 0.02 | 770.00M | 31.61B |
| Q3 FY2023 | 30 Sept 2023 | 0.03 | 793.00M | 31.11B |
| Q2 FY2023 | 30 Jun 2023 | 0.03 | 803.00M | 28.76B |
| Q1 FY2023 | 31 Mar 2023 | 0.03 | 829.00M | 27.19B |
| Q4 FY2022 | 31 Dec 2022 | 0.02 | 597.00M | 27.28B |
| Q3 FY2022 | 30 Sept 2022 | 0.02 | 629.00M | 26.66B |
| Q2 FY2022 | 30 Jun 2022 | 0.03 | 634.00M | 24.48B |
| Q1 FY2022 | 31 Mar 2022 | 0.02 | 416.00M | 22.72B |
| Q4 FY2021 | 31 Dec 2021 | 0.02 | 425.00M | 22.20B |
| Q3 FY2021 | 30 Sept 2021 | 0.02 | 437.00M | 21.29B |
| Q2 FY2021 | 30 Jun 2021 | 0.02 | 443.00M | 20.25B |
| Q1 FY2021 | 31 Mar 2021 | 0.02 | 378.00M | 20.10B |
| Q4 FY2020 | 31 Dec 2020 | 0.02 | 319.00M | 19.12B |
| Q3 FY2020 | 30 Sept 2020 | 0.02 | 337.00M | 18.48B |
| Q2 FY2020 | 30 Jun 2020 | 0.02 | 356.00M | 17.87B |
| Q1 FY2020 | 31 Mar 2020 | 0.01 | 25.59M | 2.12B |
| Q4 FY2019 | 31 Dec 2019 | 0.01 | 181.00M | 14.05B |
| Q3 FY2019 | 30 Sept 2019 | 0.02 | 188.61M | 12.51B |
| Q2 FY2019 | 30 Jun 2019 | 0.02 | 194.05M | 8.29B |
| Q1 FY2019 | 31 Mar 2019 | 0.02 | 199.43M | 8.13B |
| Q4 FY2018 | 31 Dec 2018 | 0.00 | 0.00 | 8.01B |
| Q3 FY2018 | 30 Sept 2018 | 0.00 | 0.00 | 7.08B |
| Q2 FY2018 | 30 Jun 2018 | 0.00 | 0.00 | 6.86B |
| Q1 FY2018 | 31 Mar 2018 | 0.00 | 0.00 | 6.52B |
| Q4 FY2017 | 31 Dec 2017 | 0.00 | 0.00 | 6.27B |
| Q3 FY2017 | 30 Sept 2017 | 0.00 | 0.00 | 5.47B |
| Q2 FY2017 | 30 Jun 2017 | 0.00 | 0.00 | 5.44B |
| Q1 FY2017 | 31 Mar 2017 | 0.00 | 0.00 | 5.01B |
| Q4 FY2016 | 31 Dec 2016 | 0.00 | 0.00 | 4.83B |
| Q3 FY2016 | 30 Sept 2016 | 0.00 | 0.00 | 3.93B |
| Q2 FY2016 | 30 Jun 2016 | 0.00 | 0.00 | 3.75B |
| Q1 FY2016 | 31 Mar 2016 | 0.00 | 59.00K | 3.52B |
| Q4 FY2015 | 31 Dec 2015 | 0.00 | 118.00K | 3.49B |
| Q3 FY2015 | 30 Sept 2015 | 0.00 | 178.00K | 3.04B |
| Q2 FY2015 | 30 Jun 2015 | 0.00 | 237.00K | 2.77B |
| Q1 FY2015 | 31 Mar 2015 | 0.00 | 296.00K | 2.59B |
| Q4 FY2014 | 31 Dec 2014 | 0.00 | 355.00K | 2.03B |
| Q3 FY2014 | 30 Sept 2014 | 0.00 | 415.00K | 1.93B |
| Q2 FY2014 | 30 Jun 2014 | 0.00 | 474.00K | 1.75B |
| Q1 FY2014 | 31 Mar 2014 | 0.00 | 535.00K | 1.76B |
| Q4 FY2013 | 31 Dec 2013 | 0.00 | 2.49M | 659.52M |
| Q3 FY2013 | 30 Sept 2013 | 0.31 | 156.71M | 513.35M |
| Q2 FY2013 | 30 Jun 2013 | 0.01 | 4.51M | 496.10M |
| Q1 FY2013 | 31 Mar 2013 | 0.01 | 4.73M | 488.16M |
| Q4 FY2012 | 31 Dec 2012 | 0.01 | 5.66M | 383.19M |
| Q3 FY2012 | 30 Sept 2012 | 0.02 | 7.39M | 368.35M |
| Q2 FY2012 | 30 Jun 2012 | 0.02 | 8.71M | 414.88M |
| Q1 FY2012 | 31 Mar 2012 | 0.02 | 10.31M | 427.13M |
| Q4 FY2011 | 31 Dec 2011 | 0.02 | 11.85M | 486.42M |
| Q3 FY2011 | 30 Sept 2011 | 0.03 | 13.38M | 534.78M |
| Q2 FY2011 | 30 Jun 2011 | 0.02 | 14.90M | 880.51M |
| Q1 FY2011 | 31 Mar 2011 | 0.02 | 16.41M | 958.30M |
| Q4 FY2010 | 31 Dec 2010 | 0.12 | 133.72M | 1.08B |
| Q3 FY2010 | 30 Sept 2010 | 0.02 | 19.65M | 1.15B |
| Q2 FY2010 | 30 Jun 2010 | 0.02 | 21.35M | 1.20B |
| Q1 FY2010 | 31 Mar 2010 | 0.02 | 23.06M | 1.21B |
| Q4 FY2009 | 31 Dec 2009 | 0.02 | 24.94M | 1.30B |
| Q3 FY2009 | 30 Sept 2009 | — | — | — |
| Q2 FY2009 | 30 Jun 2009 | — | — | — |
| Q1 FY2009 | 31 Mar 2009 | — | — | — |
Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters.
See also:P/E ratio,Market cap,P/S ratio,ROE (return on equity),Current ratio,All ratios
Common questions about Genmab A's debt to equity
Source: Financial Modeling Prep